Publicaciones
-
Molinos-Quintana Á, Alonso-Saladrigues A, Herrero B, Caballero-Velázquez T, Galán-Gómez V, Panesso M, Torrebadell-Burriel M, Delgado-Serrano J, Pérez de Soto C, Faura A, González-Martínez B, Castillo-Robleda A, Diaz-de-Heredia C, Pérez-Martínez A, Pérez-Hurtado JM, Rives-Solà S and Pérez-Simón JA.
Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoring
FRONTIERS IN IMMUNOLOGY . 14: 1280580-1280580. Nº de citas: 8
-
Molina O, Ortega-Sabater C, Thampi N, Fernández-Fuentes N, Guerrero-Murillo M, Martínez-Moreno A, Vinyoles M, Velasco-Hernández T, Bueno C, Trincado JL, Granada I, Campos D, Giménez C, Boer JM, den Boer ML, Calvo GF, Camós-Guijosa M, Fuster JL, Velasco P, Ballerini P, Locatelli F, Mullighan CG, Spierings DCJ, Foijer F, Pérez-García VM and Menéndez P.
Chromosomal instability in aneuploid acute lymphoblastic leukemia associates with disease progression
EMBO Molecular Medicine . 16(1): 64-92. Nº de citas: 4
-
Staniek J, Kalina T, Andrieux G, Boerries M, Janowska I, Fuentes M, Díez P, Bakardjieva M, Stancikova J, Raabe J, Neumann J, Schwenk S, Arpesella L, Stuchly J, Benes V, García Valiente R, Fernández García J, Carsetti R, Piano Mortari E, Català-Temprano A, de la Calle O, Sogkas G, Neven B, Rieux-Laucat F, Magerus A, Neth O, Olbrich P, Voll RE, Alsina L, Allende LM, Gonzalez-Granado LI, Böhler C, Thiel J, Venhoff N, Lorenzetti R, Warnatz K, Unger S, Seidl M, Mielenz D, Schneider P, Ehl S, Rensing-Ehl A, Smulski CR and Rizzi M.
Non-apoptotic FAS signaling controls mTOR activation and extrafollicular maturation in human B cells
Science immunology . 9(91): . Nº de citas: 5
-
Bueno C, Torres-Ruíz R, Velasco-Hernandez T, Molina O, Petazzi P, Martinez-Moreno A, Rodríguez-Cortez VC, Vinyoles M, Cantilena S, Williams O, Vega-García N, Rodriguez-Perales S, Segovia JC, Quintana-Bustamante O, Roy A, Meyer C, Marschalek R, Smith A, Milne TA, Fraga MF, Tejedor JRR and Menendez P.
A human genome editing-based MLL::AF4 ALL model recapitulates key cellular and molecular leukemogenic features
Blood . 142(20): 1752-1756. Nº de citas: 3
-
Morán-Alvarez, P, Andreu-Suárez, A, Caballero-Motta, L, Gassiot S, Berrueco R, Calzada-Hernández J, Vázquez-Díaz, M, Boteanu, A, Messia, V, Giovannelli, L, De Benedetti, F, Anton-Lopez J and Bracaglia, C.
Haematological and other manifestations in the presence of antiphospholipid antibodies in a multicentric paediatric cohort
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY . 41(11): 2331-2337. Nº de citas: 2
-
Berrueco R, González E, Deyà-Martinez A, Solsona M, García-García AP, Calzada-Hernández J, Luo Y, Vlagea A, Ruiz-Llobet A and Alsina L.
Mycophenolate mofetil for autoimmune cytopenias in children: high rates of response in inborn errors of immunity
Frontiers in pediatrics . 11: 1174671-1174671. Nº de citas: 3
-
Velasco P, Bautista F, Rubio A, Aguilar Y, Rives-Solà S, Dapena JL, Pérez A, Ramirez M, Saiz-Ladera C, Izquierdo E, Escudero A, Camós-Guijosa M, Vega-García N, Ortega M, Hidalgo-Gómez G, Palacio C, Menéndez P, Bueno C, Montero J, Romecín PA, Zazo S, Alvarez F, Parras J, Ortega-Sabater C, Chulián S, Rosa M, Cirillo D, García E, García J, Manzano-Muñoz A, Minguela A and Fuster JL.
The relapsed acute lymphoblastic leukemia network (ReALLNet): a multidisciplinary project from the spanish society of pediatric hematology and oncology (SEHOP)
Frontiers in pediatrics . 11: 1269560-1269560. Nº de citas: 1
-
Salmerón-Villalobos J, Castrejon-de-Anta N, Guerra-Garcia P, Ramis-Zaldivar JE, López-Guerra M, Mato S, Colomer D, Diaz Crespo FJ, Menarguez J, Garrido-Pontnou M, Andres M, Garcia-Fernandez E, Llavador M, Frigola G, Garcia N, Gonzalez-Farre B, Martin-Guerrero I, Garrido-Colino C, Astigarraga I, Fernandez A, Verdu-Amorós J, Gonzalez Muñiz S, González-Martínez B, Celis-Passini V, Campo E, Balagué O and Salaverria I.
Decoding the molecular heterogeneity of pediatric monomorphic post-solid organ transplant lymphoproliferative disorders
Blood . 142(5): 434-445. Nº de citas: 10
-
Marina Caballero Bellón, Alonso-Saladrigues A, Bobillo-Perez S, Faura A, Arqués L, Rivera C, Català-Temprano A, Dapena JL, Rives-Solà S and Jordán-García I.
Risk factors and outcome of Chimeric Antigen Receptor T-Cell patients admitted to Pediatric Intensive Care Unit: CART-PICU study
FRONTIERS IN IMMUNOLOGY . 14: 1219289-1219289. Nº de citas: 7
-
Fernandez-Sojo J, Valdivia E, Esquirol A, Portos JM, Rovira M, Suarez M, Diaz-de-Heredia C, Uría ML, Ortí G, Ferra C, Mussetti A, Paviglianiti A, Marsal-Ricoma J, Badell I, Lozano M, Gomez D, Azqueta C, Martorell L, Rubio N, Garcia-Buendia A, Villa J, Carreras E and Querol S.
Development of an in-house bone marrow collection kit: The Catalan bone marrow transplantation group experience
VOX SANGUINIS . : 783-789.